Genta Can #39;t Catch a Break Genta (GNTA:Nasdaq - news - research) is never boring! Monday night, the company announced that its phase III Genasense study in chronic lymphocytic leukemia (CLL) met its primary endpoint, which was tumor shrinkage. 

Which of the following sections of a newspaper would this article likely appear in? World News, Sports, Business, or Science and Technology? 